{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "O<sub>3</sub>", "SARS-CoV-2", "SARS-CoV-2 infection", "antioxidant", "antiviral", "autohemotherapy", "coronavirus", "ozone", "ozone therapy"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37077113", "DateCompleted": {"Year": "2023", "Month": "04", "Day": "21"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.4103/2045-9912.369237"], "Journal": {"ISSN": "2045-9912", "JournalIssue": {"Volume": "13", "Issue": "4", "PubDate": {"Year": "2023", "Season": "Oct-Dec"}}, "Title": "Medical gas research", "ISOAbbreviation": "Med Gas Res"}, "ArticleTitle": "The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): a review.", "Pagination": {"StartPage": "165", "EndPage": "171", "MedlinePgn": "165-171"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly swept across the world. As new knowledge regarding treatment options for COVID-19 has emerged, the use of ozone therapy in the context of SARS-CoV-2 infection as an integrative therapeutic option supplementary to standard treatment regimen has been assessed in the present literature. We reviewed, critically analyzed, and summarized all present published literature on ozone therapy in association with COVID-19 via the PubMed database. Various reports and studies on the use of ozone (major autohemotherapy, rectal ozone insufflation, ozone inhalation) in patients affected by COVID-19 indicate that ozone therapy may reduce morbidity and accelerate recovery, while exhibiting a high safety profile with no relevant adverse effects. Current literature suggests that integrating ozone therapy into the existing standard of care and best available therapy for the treatment of COVID-19 patients offers major advantages in terms of superior clinical outcome parameters and amelioration of laboratory results. Further prospective studies are warranted to guide the next steps in the clinical application of ozone therapy and examine its impact on the course of COVID-19."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Hospital of Munich, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany."}], "LastName": "Harapan", "ForeName": "Biyan Nathanael", "Initials": "BN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Complementary Cardiovascular Clinic (CCV Clinic), Tangerang Selatan, Indonesia."}], "LastName": "Harapan", "ForeName": "Triswan", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Med Gas Res", "NlmUniqueID": "101564536", "ISSNLinking": "2045-9912"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}], "CoiStatement": "None"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Worldometer  COVID-19 coronavirus pandemic.  https://www.worldometers.info/coronavirus/ . Accessed April 6, 2022."}, {"Citation": "Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J Neurol. 2021;268:3059\u20133071.", "ArticleIdList": ["PMC7826147", "33486564"]}, {"Citation": "Mahajan P, Dass B, Radhakrishnan N, McCullough PA. COVID-19-associated systemic thromboembolism: a case report and review of the literature. Cardiorenal Med. 2020;10:462\u2013469.", "ArticleIdList": ["PMC7649692", "33091905"]}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425\u2013435.", "ArticleIdList": ["16624639"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, Pe\u00f1a-Lora D, \u00c1lava-Rabasa S, P\u00e9rez-Moro OS. Ozone (O3) and SARS-CoV-2: physiological bases and their therapeutic possibilities according to COVID-19 evolutionary stage. SN Compr Clin Med. 2020;2:1094\u20131102.", "ArticleIdList": ["PMC7340747", "32838159"]}, {"Citation": "Tascini C, Sermann G, Pagotto A, et al. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2021;16:669\u2013675.", "ArticleIdList": ["PMC7603641", "33131033"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646\u2013682.", "ArticleIdList": ["19260079"]}, {"Citation": "Bocci V. The potential toxicity of ozone: side effects and contraindications of ozonetherapy. In: Bocci V, editor. OZONE: A new medical drug. Dordrecht: Springer Netherlands; 2011. pp. 75\u201384."}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Pablos A, et al. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261.", "ArticleIdList": ["PMC7833586", "33310665"]}, {"Citation": "Jacobs MT. Adverse effects and typical complications in ozone-oxygen therapy. Ozonachrichten. 1983;1:193\u2013201."}, {"Citation": "Cattel F, Giordano S, Bertiond C, et al. Ozone therapy in COVID-19: a narrative review. Virus Res. 2021;291:198207.", "ArticleIdList": ["PMC7585733", "33115670"]}, {"Citation": "Rowen RJ. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019;9:232\u2013237.", "ArticleIdList": ["PMC7802416", "31898609"]}, {"Citation": "Chirchiglia D, Chirchiglia P, Stroscio C, Volpentesta G, Lavano A. Suspected pulmonary embolism after oxygen-ozone therapy for low back pain. J Neurol Surg A Cent Eur Neurosurg. 2019;80:503\u2013506.", "ArticleIdList": ["31430795"]}, {"Citation": "Freund PR, Alshafai L, Margolin EA. Multifocal stroke from ozone gas emboli. J Neuroophthalmol. 2019;39:518\u2013519.", "ArticleIdList": ["30741783"]}, {"Citation": "Corea F, Amici S, Murgia N, Tambasco N. A case of vertebrobasilar stroke during oxygen-ozone therapy. J Stroke Cerebrovasc Dis. 2004;13:259\u2013261.", "ArticleIdList": ["17903984"]}, {"Citation": "He R, Huang Q, Yan X, Liu Y, Yang J, Chen X. A case of paradoxical embolism causing anterior spinal cord syndrome and acute myocardial infarction following the intradiscal oxygen-ozone therapy. Front Neurol. 2019;10:137.", "ArticleIdList": ["PMC6395432", "30853936"]}, {"Citation": "Ranaldi GT, Villani ER, Franza L. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review. Med Gas Res. 2020;10:134\u2013138.", "ArticleIdList": ["PMC8086623", "33004712"]}, {"Citation": "Clavo B, Santana-Rodr\u00edguez N, Llontop P, et al. Ozone therapy as adjuvant for cancer treatment: is further research warranted? Evid Based Complement Alternat Med. 2018;2018:7931849.", "ArticleIdList": ["PMC6151231", "30271455"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res. 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Chirumbolo S, Valdenassi L, Simonetti V, et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol. 2021;96:107777.", "ArticleIdList": ["PMC8112288", "34020394"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel) 2020;9:389.", "ArticleIdList": ["PMC7278582", "32384798"]}, {"Citation": "Bocci V, Zanardi I, Travagli V. Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Med Gas Res. 2011;1:6.", "ArticleIdList": ["PMC3231820", "22146387"]}, {"Citation": "Gavazza A, Marchegiani A, Rossi G, et al. Ozone therapy as a possible option in COVID-19 management. Front Public Health. 2020;8:417.", "ArticleIdList": ["PMC7477102", "32984235"]}, {"Citation": "Murray BK, Ohmine S, Tomer DP, et al. Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods. 2008;153:74\u201377.", "ArticleIdList": ["18598719"]}, {"Citation": "Beeraka NM, Sadhu SP, Madhunapantula SV, et al. Strategies for targeting SARS CoV-2: small molecule inhibitors-the current status. Front Immunol. 2020;11:552925.", "ArticleIdList": ["PMC7531039", "33072093"]}, {"Citation": "Chang KW, Sheng Y, Gombold JL. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein. Virology. 2000;269:212\u2013224.", "ArticleIdList": ["PMC7131280", "10725213"]}, {"Citation": "Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009;393:265\u2013271.", "ArticleIdList": ["PMC3594805", "19717178"]}, {"Citation": "\u015eahin M, Eryilmaz F, Keser \u015eahin HH. Ozone therapy may be an option for COVID-19 patients. Eur Rev Med Pharmacol Sci. 2021;25:2470\u20132472.", "ArticleIdList": ["33829430"]}, {"Citation": "Yousefi B, Banihashemian SZ, Feyzabadi ZK, et al. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med Gas Res. 2022;12:33\u201340.", "ArticleIdList": ["PMC8562402", "34677149"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879.", "ArticleIdList": ["PMC7414302", "32795898"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Isidoro T, Vil\u00e1s F. Potential role of oxygen-ozone therapy in treatment of COVID-19 pneumonia. Am J Case Rep. 2020;21:e925849.", "ArticleIdList": ["PMC7476746", "32804917"]}, {"Citation": "Wu J, Tan CS, Yu H, et al. Recovery of four COVID-19 patients via ozonated autohemotherapy. Innovation (Camb) 2020;1:100060.", "ArticleIdList": ["PMC7609231", "33169118"]}, {"Citation": "\u00c7olak \u015e, Gen\u00e7 Yavuz B, Yavuz M, et al. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int J Clin Pract. 2021;75:e14321.", "ArticleIdList": ["PMC8236993", "33971067"]}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. 2020;92:2348\u20132350.", "ArticleIdList": ["PMC7280732", "32437014"]}, {"Citation": "Araimo F, Imperiale C, Tordiglione P, et al. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021;93:2210\u20132220.", "ArticleIdList": ["33111980"]}, {"Citation": "Chirumbolo S, Franzini M, Simonetti V, et al. Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed. J Med Virol. 2021;93:2580\u20132582.", "ArticleIdList": ["PMC8013854", "33503267"]}, {"Citation": "Tirelli U, Franzini M, Valdenassi L, et al. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients. Eur Rev Med Pharmacol Sci. 2021;25:5871\u20135875.", "ArticleIdList": ["34604980"]}, {"Citation": "Shah M, Captain J, Vaidya V, et al. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study) Int Immunopharmacol. 2021;91:107301.", "ArticleIdList": ["PMC7758022", "33421928"]}, {"Citation": "Hendawy HA, Mosallam W, Abuelnaga ME, Sabry AM. Old treatment for a new disease: can rectal ozone insufflation be used for COVID-19 management? A Case Report. SN Compr Clin Med. 2021;3:1424\u20131427.", "ArticleIdList": ["PMC8046266", "33875977"]}, {"Citation": "Pe\u00f1a-Lora DY, Albaladejo-Flor\u00edn MJ, Fern\u00e1ndez-Cuadros ME. Usefulness of rectal ozonetherapy in a geriatric patient with severe COVID-19 pneumonia. Revista espanola de geriatria y gerontologia. 2020;55:362\u2013364.", "ArticleIdList": ["PMC7430238", "32900514"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, \u00c1lava-Rabasa S, et al. Effect of rectal ozone (O(3)) in severe COVID-19 pneumonia: preliminary results. SN Compr Clin Med. 2020;2:1328\u20131336.", "ArticleIdList": ["PMC7397966", "32838181"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, \u00c1lava-Rabasa S, et al. Compassionate use of rectal ozone (O(3)) in severe COVID-19 pneumonia: a case-control study. SN Compr Clin Med. 2021;3:1185\u20131199.", "ArticleIdList": ["PMC7984736", "33778374"]}, {"Citation": "Dengiz E, \u00d6zcan \u00c7, G\u00fcven Y, et al. Ozone gas applied through nebulization as adjuvant treatment for lung respiratory diseases due to COVID-19 infections: a prospective randomized trial. Med Gas Res. 2022;12:55\u201359.", "ArticleIdList": ["PMC8562398", "34677153"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "21", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "4", "Day": "20", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "4", "Day": "20", "Hour": "1", "Minute": "40"}, {"Year": "2023", "Month": "2", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37077113", "PMC10226687", "10.4103/2045-9912.369237", "MedGasRes_2023_13_4_165_369237"]}}], "PubmedBookArticle": []}